Franciely Rufino de Almeida Lima

CV Lattes ORCID

Universidade de São Paulo (USP). Faculdade de Ciências Farmacêuticas de Ribeirão Preto (FCFRP) (Institutional affiliation from the last research proposal)
Birthplace: Brazil

graduation at Farmácia from Universidade Federal de Juiz de Fora (2018). (Source: Lattes Curriculum)

News published in Agência FAPESP Newsletter about the researcher

More items Less items

TITULO

Articles published in other media outlets ( ):

More items Less items

VEICULO: TITULO (DATA)

Scholarships in Brazil

Ongoing (most recent)

Abstract
Glioblastoma affects approximately 3.21 individuals per 100,000, with a median survival of 12 months and a 5-year relative survival rate of less than 5%. Available therapies show limited efficacy due to high recurrence (~40%) and adverse effects, highlighting the need for more effective strategies with fewer side effects. Cabazitaxel (CBZ), a next-generation taxane with low affinity for P…
Development, characterization and antitumor evaluation of lactoferrin-functionalized lipid nanoparticles for glioblastoma: Integration of natural products and antitumor agents, BP.DD

Virtual Library in numbers * Updated data on August 09, 2025

Total / Available in English

1 / 1	Ongoing scholarships in Brazil

Associated processes

Most frequent collaborators in research granted by FAPESP

Priscyla Daniely Marcato Gaspari

Keywords used by the researcher

Health Sciences Pharmacy

Please report errors on the page using this form.

Short URL

Abstract